Quantum BioPharma Ltd. Adjustments For Decrease Increase In Other Current Assets
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Decrease Increase In Other Current Assets of $86.38 thousand for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-03-31.
Financial Statements › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets · last filed 2025-03-31
- Quantum BioPharma Ltd. adjustments for decrease increase in other current assets for the quarter ending 2024-12-31 was $81.29K, a 57.87% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for decrease increase in other current assets for the quarter ending 2024-09-30 was -$19.90K, a 112.90% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for decrease increase in other current assets for the quarter ending 2023-12-31 was $192.95K.
- Quantum BioPharma Ltd. adjustments for decrease increase in other current assets for the quarter ending 2023-09-30 was $154.32K.
| Period end | Adjustments For Decrease Increase In Other Current Assets 3 month | Adjustments For Decrease Increase In Other Current Assets 6 month | Adjustments For Decrease Increase In Other Current Assets 9 month | Adjustments For Decrease Increase In Other Current Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $81.29K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | $61.39K derived: sum of 2 quarters · filed 2025-03-31 | $86.38K 20-F/A · filed 2025-03-31 | |
| 2024-09-30 | -$19.90K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $5.09K 6-K · filed 2024-11-12 | ||
| 2024-06-30 | $24.99K 6-K/A · filed 2024-08-19 | |||
| 2023-12-31 | $192.95K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | $347.27K derived: sum of 2 quarters · filed 2025-03-31 | $316.72K 20-F/A · filed 2025-03-31 | |
| 2023-09-30 | $154.32K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $123.77K 6-K · filed 2024-11-12 | ||
| 2023-06-30 | -$30.55K 6-K/A · filed 2024-08-19 | |||
| 2022-12-31 | $795.93K 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | -$609.15K 20-F · filed 2024-04-02 |